Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Wellgistics Health (WGRX) EBITDA Margin (2024 - 2025)

Wellgistics Health's EBITDA Margin history spans 2 years, with the latest figure at 2821.3% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 285150.0% year-over-year to 2821.3%, compared with a TTM value of 91.11% through Dec 2025, down 5721.0%, and an annual FY2025 reading of 91.11%, down 5721.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 2821.3% at Wellgistics Health, up from 1047.11% in the prior quarter.
  • The five-year high for EBITDA Margin was 2821.3% in Q4 2025, with the low at 1286.52% in Q2 2024.